Protective effects of amoxicillin and probiotics on colon disorders in an experimental model of acute diverticulitis disease.

Abstract

Acute diverticulitis disease is associated with inflammation and infection in the colon diverticula and may lead to severe morbidity. This study aimed to evaluate and compare the protective effects of amoxicillin antibiotic, either alone or in combination with probiotics (Lactobacillus acidophilus and Bifidobacterium lactis), in a rat model of acute diverticulitis disease. Acute diverticulitis was induced, in albino rats, by adding 3% weight/volume of dextran sulfate sodium (DSS) to the rats' drinking water; daily for 7 days, in addition to injecting lipopolysaccharide (LPS) enema (4 mg/kg). The impact of treatments was assessed by measuring the physiological and immunological parameters and evaluating colon macroscopic and microscopic lesions. The results showed that both treatments (especially probiotics with amoxicillin) alleviated the adverse effects of DSS and LPS. This was obvious through the modulation of the rats' body weight and the colon weight-to-length ratio. Also, there was a significant (p < 0.001) decrease in the colon macroscopic lesion score. The pro-inflammatory cytokines [(TNF)-α, (IL)-1β, (IFN)-γ, and (IL)-18]; in the colon tissue; were significantly (p < 0.001) decreased. Also, both treatments significantly ameliorated the elevation of myeloperoxidase activity and C-reactive protein levels, in addition to improving the histopathological alterations in the colon tissue. In conclusion, amoxicillin and probiotics-amoxicillin were effective in preventing the development of experimentally induced acute diverticulitis, through their anti-inflammatory and immunomodulatory effects. Furthermore, this study has explored the role of probiotics in preventing DSS/LPS-induced acute diverticulitis, so it can be applied as a promising treatment option for acute diverticulitis disease.

• Authors: Maha G Soliman, Hanaa A Mansour, Wedad A Hassan, Eman Shawky
• Journal: Inflammopharmacology (Inflammopharmacology) Vol. 30 Issue 6 Pg. 2153-2165 (Dec 2022) ISSN: 1568-5608 [Electronic] Switzerland
• PMID: 36318434 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s).

Chemical References

• Amoxicillin
• Cytokines
• Dextran Sulfate
• Lipopolysaccharides
• Tumor Necrosis Factor-alpha

Topics

• Animals
• Amoxicillin (adverse effects, metabolism)
• Colitis (chemically induced)
• Colon
• Cytokines (metabolism)
• Dextran Sulfate (pharmacology)
• Disease Models, Animal
• Diverticulitis (metabolism, pathology)
• Lipopolysaccharides (pharmacology)
• Models, Theoretical
• Probiotics (pharmacology)
• Tumor Necrosis Factor-alpha (metabolism)
• Rats